Hirejobs Canada
Register
Auckland Jobs
Canterbury Jobs
Northland Jobs
Otago Jobs
Southland Jobs
Tasman Jobs
Wellington Jobs
West Coast Jobs
Oil & Gas Jobs
Banking Jobs
Construction Jobs
Top Management Jobs
IT - Software Jobs
Medical Healthcare Jobs
Purchase / Logistics Jobs
Sales
Ajax Jobs
Designing Jobs
ASP .NET Jobs
Java Jobs
MySQL Jobs
Sap hr Jobs
Software Testing Jobs
Html Jobs
IT Jobs
Logistics Jobs
Customer Service Jobs
Airport Jobs
Banking Jobs
Driver Jobs
Part Time Jobs
Civil Engineering Jobs
Accountant Jobs
Safety Officer Jobs
Nursing Jobs
Civil Engineering Jobs
Hospitality Jobs
Part Time Jobs
Security Jobs
Finance Jobs
Marketing Jobs
Shipping Jobs
Real Estate Jobs
Telecom Jobs

Importance and function of Ikaros isoforms in the context of genotoxic chemotherapy - Jobs in Montréal, QC

Job LocationMontréal, QC
EducationNot Mentioned
SalaryNot Disclosed
IndustryNot Mentioned
Functional AreaNot Mentioned
Job TypeFull Time

Job Description

Importance and function of Ikaros isoforms in the context of genotoxic chemotherapyRéf ABG-107480 Sujet de Thèse13/09/2022 Autre financement publicUniversité de Montréal / Centre de recherche Hôpital Maisonneuve-RosemontLieu de travailMontréal - CanadaIntitulé du sujetImportance and function of Ikaros isoforms in the context of genotoxic chemotherapyChamps scientifiques

  • Biochimie
  • Biologie
  • Santé, médecine humaine, vétérinaire
Description du sujetGenotoxic chemotherapy is a preeminent therapeutic option for Acute Lymphoblastic Leukemia (ALL), the most frequent childhood cancer. While therapy efficacy has seen improvements in recent years, a significant fraction of ALL patients still succumbs to this disease. Thus, it is critical to investigate mechanisms that influence treatment response in leukemias, including ALL.Mutation or overexpression of dominant negative isoforms of the transcription factor Ikaros typifies a significant portion of high-risk ALL, and chronic lymphocytic leukemia (CML) at blast crisis. It is currently unclear whether the tumor suppressor Ikaros possesses functions outside or complementary to gene regulation that might influence carcinogenesis and response to treatment. Interestingly, the detection of DNA double-strand break marks is increased in hematopoietic cells whereby Ikaros is mutated. Preliminary results suggest that certain isoforms of Ikaros can rescue this phenotype in Ikaros mutated model cell lines. Thus, the absence of certain Ikaros isoforms could increase genomic instability. The aim of this project is to determine whether certain isoforms of Ikaros can promote genomic stability and thereby, influence the response to chemotherapy. The mechanism and functions exerted by Ikaros isoforms will be investigated.For this study, we are using ALL and CML cell lines, and results obtained with these cells are compared to those obtained in hematopoietic cells of mouse models. We propose to define the effect of Ikaros disruption on genomic stability of hematopoietic cells when exposed to chemotherapeutic agents. Effect of the absence of Ikaros as well as the effect of different Ikaros isoforms on DNA repair mechanisms will be investigated. To define whether different isoforms of Ikaros could participate to DNA repair and exert specific nuclear activities, their protein interactome will be defined and compared when the cells are exposed or not to chemotherapeutic agents. To discriminate between direct and indirect effect of Ikaros isoforms on genomic stability, a comparative analysis of the genome wide recruitment of different Ikaros isoforms will be performed, and their effect of the transcriptome of hematopoietic cells at steady state or upon treatment with chemotherapeutic agents will be questioned.Thus, this study will assess whether the Ikaros isoforms can have specific roles in modulating genomic stability, transcriptome in stress condition, and thus, the chemotherapy efficacy.The current study involves a combination of high-throughput screenings, proteomics, molecular genetics, cellular and biochemical methods. In addition to perform experiments, the trainee will participate to experiment planification, result analyses and discussion regarding the orientation of the project. Guidance will also be provided for literature review and writing of scientific communications. The trainee will also attend and participate to lab meetings, HMR research center student’s seminars, international scientific presentations and meetings. English and French languages are used in the laboratory and the research center.Prise de fonction :12/09/2022Nature du financementAutre financement publicPrécisions sur le financementFond de recherche des IRSC/CIHRPrésentation établissement et labo daccueilUniversité de Montréal / Centre de recherche Hôpital Maisonneuve-RosemontThe HMR Research Center is organised in three different biomedical research areas: Oncology-immunology, Nephrology and Vision health. The research center includes more than 60 research groups and over 150 graduate students and post-doctoral fellows. The research center includes high tech equipment and multiple specialized platforms.The host laboratory is investigating the biological effect of factors abnormally regulated or mutated in leukemias and in other forms of hematological malignancies. Understanding how factors critical for hematopoietic cell fate can influence the cellular answer to stress conditions is of major interest to fully define the initial steps of carcinogenesis. Mouse models, human samples and human cell lines are used in combination with omics and biochemical, molecular and cellular biology approaches.Profil du candidatThe candidate should have training in biochemistry, molecular biology, cellular biology or a related discipline. The candiate must have a bachelor or master degree with strong GPA. S/he should be motivated, hard working, and a team player.Quick Apply
  • Terms & Conditions
  • New Privacy
  • Privacy Center
  • Accessibility
For Job Seekers
  • Browse Jobs
  • Advanced Job Search
  • Emplois Quebec
For Employers
  • Post a Job
  • SimplyHired OnDemand
Stay Connected

APPLY NOW

© 2021 HireJobsCanada All Rights Reserved